GTP binding by class II transactivator: Role in nuclear import

Science

Volumn 285, Issue 5432, 1999, Pages 1402-1408

  Harton, Jonathan A ^a,b   Cressman, Drew E ^a   Chin, Keh Chuang ^a,c   Der, Channing J ^a,b   Ting, Jenny P Y ^a,b  

^a UNIVERSITY OF NORTH CAROLINA   (United States)

^b UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^c YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GUANINE NUCLEOTIDE BINDING PROTEIN; GUANOSINE TRIPHOSPHATASE; HLA D ANTIGEN; TRANSACTIVATOR PROTEIN;

ARTICLE; ENZYME ACTIVITY; GENE MUTATION; HUMAN; ONCOGENE RAS; PRIORITY JOURNAL; PROTEIN BINDING; TRANSACTIVATION;

ADENOSINE TRIPHOSPHATE; ANIMALS; BINDING SITES; CELL LINE; CELL NUCLEUS; COS CELLS; GENES, MHC CLASS II; GTP-BINDING PROTEINS; GUANOSINE TRIPHOSPHATE; HLA-DR ANTIGENS; HUMANS; MUTATION; NUCLEAR PROTEINS; PROMOTER REGIONS (GENETICS); TEMPERATURE; TRANS-ACTIVATION (GENETICS); TRANS-ACTIVATORS; TRANSCRIPTION FACTORS;

EID: 0033610093     PISSN: 00368075     EISSN: None     Source Type: Journal    
DOI: 10.1126/science.285.5432.1402     Document Type: Article

References (55)

1. V. Steimle, C. A. Siegrist, A. Mottet, B. Lisowska-Grospierre, B. Mach, Science 265, 106 (1994); K.-C. Chin et al., Immunity 1, 687 (1994); C. H. Chang and R. A. Flavell, J. Exp. Med. 181, 765 (1995).
2. V. Steimle, C. A. Siegrist, A. Mottet, B. Lisowska- Grospierre, B. Mach, Science 265, 106 (1994); K.-C. Chin et al., Immunity 1, 687 (1994); C. H. Chang and R. A. Flavell, J. Exp. Med. 181, 765 (1995).
3. V. Steimle, C. A. Siegrist, A. Mottet, B. Lisowska- Grospierre, B. Mach, Science 265, 106 (1994); K.-C. Chin et al., Immunity 1, 687 (1994); C. H. Chang and R. A. Flavell, J. Exp. Med. 181, 765 (1995).
4. V. Steimle, L. A. Often, M. Zufferey, B. Mach, Cell 75, 135 (1993).
5. C.-H. Chang, S. Guerder, S.-C. Hong, W. van Ewijk, R. A. Flavell, Immunity 4, 167 (1996).
6. J. L. Riley, S. D. Westerheide, J. A. Price, J. A. Brown, J. M. Boss, ibid. 2, 533 (1995); H. Zhou and L. H. Glimcher, ibid., p. 545.
7. J. L. Riley, S. D. Westerheide, J. A. Price, J. A. Brown, J. M. Boss, ibid. 2, 533 (1995); H. Zhou and L. H. Glimcher, ibid., p. 545.
8. T. Scholl, S. K. Mahanta, J. L. Strominger, Proc. Natl. Acad. Sci. U.S.A. 94, 6330 (1997); S. K. Mahanta, T. Scholl, F. C. Yang, J. L. Strominger, ibid. p. 6324; J. D. Fontes, N. Jabrane-Ferrat, C. R. Toth, B. M. Petertin, J. Exp. Med. 183, 2517 (1996); A. Kretsovali et al., Mol. Cell Biol. 18, 6777 (1998); J. D. Fontes, S. Kanazawa, D. Jean, B. M. Peterlin, ibid. 19, 941 (1999).
9. T. Scholl, S. K. Mahanta, J. L. Strominger, Proc. Natl. Acad. Sci. U.S.A. 94, 6330 (1997); S. K. Mahanta, T. Scholl, F. C. Yang, J. L. Strominger, ibid. p. 6324; J. D. Fontes, N. Jabrane-Ferrat, C. R. Toth, B. M. Petertin, J. Exp. Med. 183, 2517 (1996); A. Kretsovali et al., Mol. Cell Biol. 18, 6777 (1998); J. D. Fontes, S. Kanazawa, D. Jean, B. M. Peterlin, ibid. 19, 941 (1999).
10. T. Scholl, S. K. Mahanta, J. L. Strominger, Proc. Natl. Acad. Sci. U.S.A. 94, 6330 (1997); S. K. Mahanta, T. Scholl, F. C. Yang, J. L. Strominger, ibid. p. 6324; J. D. Fontes, N. Jabrane-Ferrat, C. R. Toth, B. M. Petertin, J. Exp. Med. 183, 2517 (1996); A. Kretsovali et al., Mol. Cell Biol. 18, 6777 (1998); J. D. Fontes, S. Kanazawa, D. Jean, B. M. Peterlin, ibid. 19, 941 (1999).
11. T. Scholl, S. K. Mahanta, J. L. Strominger, Proc. Natl. Acad. Sci. U.S.A. 94, 6330 (1997); S. K. Mahanta, T. Scholl, F. C. Yang, J. L. Strominger, ibid. p. 6324; J. D. Fontes, N. Jabrane-Ferrat, C. R. Toth, B. M. Petertin, J. Exp. Med. 183, 2517 (1996); A. Kretsovali et al., Mol. Cell Biol. 18, 6777 (1998); J. D. Fontes, S. Kanazawa, D. Jean, B. M. Peterlin, ibid. 19, 941 (1999).
12. T. Scholl, S. K. Mahanta, J. L. Strominger, Proc. Natl. Acad. Sci. U.S.A. 94, 6330 (1997); S. K. Mahanta, T. Scholl, F. C. Yang, J. L. Strominger, ibid. p. 6324; J. D. Fontes, N. Jabrane-Ferrat, C. R. Toth, B. M. Petertin, J. Exp. Med. 183, 2517 (1996); A. Kretsovali et al., Mol. Cell Biol. 18, 6777 (1998); J. D. Fontes, S. Kanazawa, D. Jean, B. M. Peterlin, ibid. 19, 941 (1999).
13. Abbreviations for amino acid residues are as follows: A, Ala; C, Cys; D, Asp; E, Glu; F, Phe; G, Gly; H, His; I, Ile; K, Lys; L, Leu; M, Met; N, Asn; P, Pro; Q, Gln; R, Arg; S, Ser; T, Thr; V, Val; W, Trp; X, any or other Y, Tyr.
14. K. C. Chin, G. G. Li, J. P. Ting, Proc. Natl. Acad. Sci. U.S.A. 94, 2501 (1997).
15. H. R. Bourne, D. A. Sanders, F. McCormick, Nature 349, 117 (1991); T. E. Dever, M. J. Glynias, W. C. Merrick, Proc. Natl. Acad. Sci. U.S.A. 84, 1814 (1987).
16. H. R. Bourne, D. A. Sanders, F. McCormick, Nature 349, 117 (1991); T. E. Dever, M. J. Glynias, W. C. Merrick, Proc. Natl. Acad. Sci. U.S.A. 84, 1814 (1987).
17. M. Trahey and F. McCormick, Science 238, 542 (1987); A. Wolfman and I. G. Macara, ibid. 248, 67 (1990).
18. M. Trahey and F. McCormick, Science 238, 542 (1987); A. Wolfman and I. G. Macara, ibid. 248, 67 (1990).
19. R. Foster et al., Mol. Cell Biol. 16, 2689 (1996); L. A. Quilliam et al., ibid. 10, 2901 (1990); P. A. Hart and C. J. Marshall, Oncogene 5, 1099 (1990).
20. R. Foster et al., Mol. Cell Biol. 16, 2689 (1996); L. A. Quilliam et al., ibid. 10, 2901 (1990); P. A. Hart and C. J. Marshall, Oncogene 5, 1099 (1990).
21. R. Foster et al., Mol. Cell Biol. 16, 2689 (1996); L. A. Quilliam et al., ibid. 10, 2901 (1990); P. A. Hart and C. J. Marshall, Oncogene 5, 1099 (1990).
22. C. D. Nobes et al., J. Cell Biol. 141, 187 (1998); R. M. Guasch, P. Scambler, G. E. Jones, A. J. Ridley, Mol. Cell. Biol. 18, 4761 (1998).
23. C. D. Nobes et al., J. Cell Biol. 141, 187 (1998); R. M. Guasch, P. Scambler, G. E. Jones, A. J. Ridley, Mol. Cell. Biol. 18, 4761 (1998).
24. G. M. Bokoch and C. J. Der, FASEB J. 7, 750 (1993); M. S. Moore and G. Blobel, Nature 365, 661 (1993); C. D. Nobes and A. Hall, Cell 81, 53 (1995).
25. G. M. Bokoch and C. J. Der, FASEB J. 7, 750 (1993); M. S. Moore and G. Blobel, Nature 365, 661 (1993); C. D. Nobes and A. Hall, Cell 81, 53 (1995).
26. G. M. Bokoch and C. J. Der, FASEB J. 7, 750 (1993); M. S. Moore and G. Blobel, Nature 365, 661 (1993); C. D. Nobes and A. Hall, Cell 81, 53 (1995).
27. G. R. Post and J. H. Brown, FASEB J. 10, 741 (1996).
28. M. Kjeldgaard, J. Nyborg, B. F. Clark, ibid., p. 1347.
29. J. A. Harton, unpublished material.
30. S. R. Sprang, Annu. Rev. Biochem. 66, 639 (1997).
31. J. M. Zhong, M. C. Chen-Hwang, Y. W. Hwang, J. Biol. Chem. 270, 10002 (1995); B. Yu, V. Z. Slepak, M. I. Simon, ibid. 272, 18015 (1997); I. S. Sigal et al., Proc. Natl. Acad. Sci. U.S.A. 83, 952 (1986).
32. J. M. Zhong, M. C. Chen-Hwang, Y. W. Hwang, J. Biol. Chem. 270, 10002 (1995); B. Yu, V. Z. Slepak, M. I. Simon, ibid. 272, 18015 (1997); I. S. Sigal et al., Proc. Natl. Acad. Sci. U.S.A. 83, 952 (1986).
33. J. M. Zhong, M. C. Chen-Hwang, Y. W. Hwang, J. Biol. Chem. 270, 10002 (1995); B. Yu, V. Z. Slepak, M. I. Simon, ibid. 272, 18015 (1997); I. S. Sigal et al., Proc. Natl. Acad. Sci. U.S.A. 83, 952 (1986).
34. All mutants used in this report were sequenced to verify the intended mutation. Immunoblottingwas performed to verify that expression of these constructs was comparable to that of wild-type CIITA expressing transfectants (available as supplementary material at www. sciencemag.org/feature/data/103790e.shl).
35. J. A. Harton, unpublished material.
36. S. Atherton-Fessler, L. L. Parker, R. L. Geahlen, H. Piwnica-Worms, Mol. Cell Biol. 13, 1675 (1993); S. Ramaswamy and P. Kaur, J. Biol. Chem. 273, 9243 (1998).
37. S. Atherton-Fessler, L. L. Parker, R. L. Geahlen, H. Piwnica-Worms, Mol. Cell Biol. 13, 1675 (1993); S. Ramaswamy and P. Kaur, J. Biol. Chem. 273, 9243 (1998).
38. These data are available as a supplementary figure at www.sciencemag.org/feature/data/1037908.shl.
39. J. A. Harton, unpublished material.
40. M. Barbacid, Annu. Rev. Biochem. 56, 779 (1987).
41. C. J. Der, T. Finkel, C. M. Cooper, Cell 44, 167 (1986); F. R. Bischoff, C. Klebe, J. Kretschmer, A. Wittinghofer, H. Ponstingl, Proc. Natl. Acad. Sci. U.S.A. 91, 2587 (1994); C. A. Landis et al., Nature 340, 592 (1989).
42. C. J. Der, T. Finkel, C. M. Cooper, Cell 44, 167 (1986); F. R. Bischoff, C. Klebe, J. Kretschmer, A. Wittinghofer, H. Ponstingl, Proc. Natl. Acad. Sci. U.S.A. 91, 2587 (1994); C. A. Landis et al., Nature 340, 592 (1989).
43. C. J. Der, T. Finkel, C. M. Cooper, Cell 44, 167 (1986); F. R. Bischoff, C. Klebe, J. Kretschmer, A. Wittinghofer, H. Ponstingl, Proc. Natl. Acad. Sci. U.S.A. 91, 2587 (1994); C. A. Landis et al., Nature 340, 592 (1989).
44. D. E. Cressman, K.-C. Chin, D. J. Taxman, J. P.-Y. Ting, Immunity 10, 163 (1999).
45. D. E. Cressman, J. A. Harton, K. C. Chin, J.P.-Y. Ting, unpublished material.
46. J. S. Dayton, T. Lindsten, C. B. Thompson, B. S. Mitchell, J. Immunol. 152, 984 (1994); L. A. Turka, J. Dayton, G. Sinclair, C. B. Thompson, B. S. Mitchell, J. Clin. Invest. 87, 940 (1991).
47. J. S. Dayton, T. Lindsten, C. B. Thompson, B. S. Mitchell, J. Immunol. 152, 984 (1994); L. A. Turka, J. Dayton, G. Sinclair, C. B. Thompson, B. S. Mitchell, J. Clin. Invest. 87, 940 (1991).
48. J. J. Gu, J. Spychala, B. S. Mitchell, J. Biol. Chem. 272, 4458 (1997); F. R. Collart and E. Huberman, Mol. Cell. Biol. 7, 3328 (1987).
49. J. J. Gu, J. Spychala, B. S. Mitchell, J. Biol. Chem. 272, 4458 (1997); F. R. Collart and E. Huberman, Mol. Cell. Biol. 7, 3328 (1987).
50. J. G. Monroe and J. C. Cambier, J. Immunol. 130, 626 (1983).
51. C. L. Peterson, A. Dingwall, M. P. Scott, Proc. Natl. Acad. Sci. U.S.A. 91, 2905 (1994); T. Tsukiyama, P. B. Becker, C. Wu, Nature 367, 525 (1994).
52. C. L. Peterson, A. Dingwall, M. P. Scott, Proc. Natl. Acad. Sci. U.S.A. 91, 2905 (1994); T. Tsukiyama, P. B. Becker, C. Wu, Nature 367, 525 (1994).
53. 32P]GTP was assayed on a scintillation counter. For GTPase assays, IPs were prepared as described above and tested for GTPase activity with CIITAs incubated at 37°C as the only modification.
54. 2 and protease inhibitors. NF-YA, CIITA, and G3 constructs were immunoprecipitated with anti-FLAG(M2) and Ras was immunoprecipitated with anti-Ras. Elution and thin-layer chromatography (TLC) were performed as described by Overmeyer et at. The results were quantitated by phosphoimage analysis, and background counts were subtracted. The differences in the molecular weights of molecules were normalized to NF-Y.
55. Supported by grants from the National Institutes of Health (NIH) (Al45580, Al41751, and Al29564 to J.P.-Y.T.; CA42978 to C.J.D.), the National Multiple Sclerosis Society (7815 to J.P.-Y.T.), and NIH training grants (D.E.C. and J.A.H.). D.E.C. is supported by an NIH postdoctoral fellowship. J.A.H. is supported by a postdoctoral fellowship from the American Cancer Society. We thank A. Cox, S. Campbell, and L. Quilliam for helpful advice.